LMD.V : Summary for LED MEDICAL DIAGNOSTICS INC - Yahoo Finance

Canadian Markets open in 9 hrs 2 mins

LED Medical Diagnostics Inc. (LMD.V)

TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
0.09+0.01 (+6.25%)
At close: 11:53AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close0.08
Bid0.08 x
Ask0.09 x
Day's Range0.08 - 0.09
52 Week Range0.05 - 0.19
Avg. Volume158,754
Market Cap31.74M
PE Ratio (TTM)-1.77
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Accesswire17 days ago

    LED Medical Diagnostics Announces Participation at Bloom Burton & Co. Healthcare Investor Conference and Grant of Stock Options

    VANCOUVER, BC / ACCESSWIRE / April 10, 2017 / LED Medical Diagnostics Inc. ("LED" or the "Company") (TSX-V: LMD) has announced that it will be participating at the sixth annual Bloom ...

  • Accesswire2 months ago

    New X-ray Imaging Patent Issued to LED Subsidiary Apteryx, Inc.

    LED Subsidiary Adds to its Intellectual Property Portfolio with US Patent Directed to X-ray Image Acquisition and Processing Systems VANCOUVER, BC / ACCESSWIRE / March 8, 2017 / LED Medical Diagnostics ...

  • Zacks Small Cap Research2 months ago

    LMD.V: Apteryx Looks To Be Great Fit for LED Medical

    LED mentioned little after that regarding the potential acquisition until this January when they announced their intent to acquire Apteryx, Inc., an Ohio-based company which develops and sells software primarily for the dental industry.  The deal closed earlier this week. Apteryx looks like it could be a great fit for LED given that there appears to be some potential significant synergies among the companies’ product portfolios and customer call points.  Apteryx brings the dental imaging and database software that supports LED’s digital imaging hardware – providing a one-stop-shop for dental practices.  Apteryx’s software licensing and recurring revenue business model will also provide welcome diversity and smoothing to LED’s capital product sale revenue stream – which is typically highly seasonal and based on the dental industry’s capex purchasing patterns.